REGENERON GENETICS CENTER Trademark

Trademark Overview

On Thursday, May 28, 2015, a trademark application was filed for REGENERON GENETICS CENTER with the United States Patent and Trademark Office. The USPTO has given the REGENERON GENETICS CENTER trademark a serial number of 86644144. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, November 2, 2023. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The REGENERON GENETICS CENTER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the field of genetics, genetic engineering, genetic sequencing, disease modeling, pharmacogenomics, and precision medicine
regeneron genetics center

General Information

Serial Number86644144
Word MarkREGENERON GENETICS CENTER
Filing DateThursday, May 28, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, November 2, 2023
Registration Number5200549
Registration DateTuesday, May 9, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2016

Trademark Statements

Disclaimer with Predetermined Text"GENETICS CENTER"
Goods and ServicesScientific research in the field of genetics, genetic engineering, genetic sequencing, disease modeling, pharmacogenomics, and precision medicine

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 3, 2015
Primary Code042
First Use Anywhere DateSunday, March 9, 2014
First Use In Commerce DateSunday, March 9, 2014

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Thursday, November 2, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, November 2, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, November 2, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 4, 2023TEAS SECTION 8 & 15 RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 9, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 9, 2017REGISTERED-PRINCIPAL REGISTER
Saturday, April 1, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 31, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 8, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, March 3, 2017USE AMENDMENT FILED
Friday, March 3, 2017TEAS STATEMENT OF USE RECEIVED
Saturday, September 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 23, 2016SOU EXTENSION 1 GRANTED
Tuesday, September 6, 2016SOU EXTENSION 1 FILED
Thursday, September 22, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 6, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, March 8, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2016PUBLISHED FOR OPPOSITION
Thursday, December 24, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 23, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 14, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 14, 2015NON-FINAL ACTION E-MAILED
Monday, September 14, 2015NON-FINAL ACTION WRITTEN
Friday, September 4, 2015ASSIGNED TO EXAMINER
Wednesday, June 3, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 1, 2015NEW APPLICATION ENTERED

Related Keywords

center genetics regeneron genetic modeling pharmacogenomics precision medicine disease engineering research field